ABILITY OF THE 1992 AND 1997 AMERICAN JOINT COMMITTEE ON CANCER STAGING SYSTEMS FOR PROSTATE CANCER TO PREDICT PROGRESSION-FREE SURVIVAL AFTER RADICAL PROSTATECTOMY FOR STAGE T2 DISEASE
- 1 July 2000
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 164 (1) , 89-92
- https://doi.org/10.1016/s0022-5347(05)67455-1
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Outcome evaluation of the 1997 American Joint Committee on Cancer staging system for prostate carcinoma treated by radiation therapyCancer, 1999
- CANCER RECURRENCE AND SURVIVAL RATES AFTER ANATOMIC RADICAL RETROPUBIC PROSTATECTOMY FOR PROSTATE CANCERJournal of Urology, 1998
- Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional updatePublished by American Medical Association (AMA) ,1997
- PROSTATE-SPECIFIC ANTIGEN AFTER ANATOMIC RADICAL RETROPUBIC PROSTATECTOMYUrologic Clinics of North America, 1997
- Can Radical Prostatectomy Alter the Progression of Poorly Differentiated Prostate Cancer?Journal of Urology, 1994
- Long-Term (15 Years) Results After Radical Prostatectomy For Clinically Localized (Stage T2c Or Lower) Prostate CancerJournal of Urology, 1994
- The Incidence and Significance of Detectable Levels of Serum Prostate Specific Antigen After Radical ProstatectomyJournal of Urology, 1994
- 5-Year Tumor Recurrence Rates After Anatomical Radical Retropubic Prostatectomy For Prostate CancerJournal of Urology, 1994
- Hormone therapy in prostatic cancerThe American Journal of Medicine, 1956